MEDICINAL PLANTS, TRADITIONAL MEDICINE AND DRUG DISCOVERY Gordon Cragg, Ph.D. NIH Special Volunteer Natural Products Branch Developmental Therapeutics Program Division of Cancer Treatment and Diagnosis NCI-Frederick Fairview Center, Suite 206 P. O. Box B Frederick, MD 21702-1201, U. S. A. Phone: 301-846-5387; fax: 301-846-6178 e-mail: [email protected]website: http://dtp.nci.nih.gov ; http://dtp.nci.nih.gov/branches/npb/index.html
32
Embed
MEDICINAL PLANTS, TRADITIONAL MEDICINE AND DRUG DISCOVERYsiteresources.worldbank.org/EXTINDKNOWLEDGE/... · MEDICINAL PLANTS, TRADITIONAL MEDICINE AND DRUG DISCOVERY ... Traditional
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
MEDICINAL PLANTS, TRADITIONAL MEDICINEAND DRUG DISCOVERY
Gordon Cragg, Ph.D.NIH Special VolunteerNatural Products BranchDevelopmental Therapeutics ProgramDivision of Cancer Treatment and DiagnosisNCI-FrederickFairview Center, Suite 206P. O. Box BFrederick, MD 21702-1201, U. S. A.
• Flavopiridol: Synthetic based on rohutikine fromDysoxylum binectariferum/India
• Combretastatins: Combretum caffrum/S. Africa
Indigofera tinctoriaIsatis indigotia
Qing Dai: Used in TCMfor treatment of myelocytic leukemia.
Source of indirubin: CDKinhibitor.
Indirubin Derivatives
NH
NH
R2
O
R1
Indirubin R1 = H R2 = O R3 = H Indirubin-3'-monooxime R1 = H R2 = N-OH R3 = H Indirubin-5-sulphonic acid R1 = H R2 = O R3 = SO3H
R3
Derivatives show selective activity against CDK1
INTERNATIONAL COLLABORATION
• Prior informed consent/permits from Source CountryGovernment and stakeholders.
• Collaboration with Source Country Organizations.• Training and technology transfer.• Protection of environment and sustainable development.• Plans for benefit-sharing
Dr. D. SoejartoU. Illinois at Chicago
The late Don Eligio Panti, traditional healer from Belize, receiving Certificate of Recognition for services to
New York Botanical Garden in their collection program for the National Cancer Institute
The late Don Eligio Panti consulting in Belize
TRADITIONAL HEALER. WESTERN SAMOA
Dr. Paul Cox, National Tropical Botanical Garden
CONTRIBUTION OF SAMOAN TRADITIONAL HEALERSPOTENTIAL ANTI-HIV DRUG FROM HOMALANTHUS NUTANS
Licensed by NIH to the AIDS ReSearchAlliance of America.Agreement with Government of Samoa.Milestone payments on completion ofPhase I, II and III clinical trials.Royalties totaling 20% of net revenues.
D.D. Soejarto, University of Illinois at Chicago
Calophyllum teysmannii var. inophylloide. Sustainable source of potential anti-AIDSdrug, calanolide B. Discovery from tree in Sarawak, Malaysia, promoted conservation and replanting of seedlings in clearcutregions, and led to establishment of theSarawak Biodiversity Center for in-countryresearch on drug discovery from local biodiversity
O
O O O
OH
O
O O O
OH
(+) - Calanolide A (-) - Calanolide B
CALANOLIDESDEVELOPMENT
1995: Calanolides licensed to Medichem Research Inc.
Synthesis of (+)-calanolide A supported by NCI SBIR grant
Negotiation with Sarawak State Govt. required by LOC1996: Joint venture company, Sarawak MedichemPharmaceuticals formed
Phase I trials of Calanolide-A completed/well tolerated
Phase II trials in progress
Calanolide B in preclinical development
NCI MEMORANDUM OF UNDERSTANDING
Agreements with qualified Source Country Organizations.
SCO performs collections, extractions, prescreening andbioassay-guided fractionation in-country at own expense.
NCI assists SCO to establish screening facility throughprovision of training and cell lines at NCI expense.
NCI provides free secondary in vitro and in vivo testingwith no IPR claims.
SCO applies for appropriate patent coverage.
NCI collaborates in development of SCO drugs meetingNCI selection criteria – at NCI expense
NCI MEMORANDUM OF UNDERSTANDING
MOUs have been signed with organizations in the followingcountries:
Australia, Bangladesh, Brazil (5), China (3), Costa Rica,
Fiji, Iceland, Korea, Mexico, New Zealand, Nicaragua,
Pakistan, Papua New Guinea, Panama, South Africa (2),
Zimbabwe
Studies on Anticancer Drug Discovery and
Development from Brazilian Biodiversity
Laboratory of Experimental Oncology– LOEClinical Pharmacology Unit - UNIFAC
Department of Physiology and PharmacologyFederal University of Ceará
www.loe.ufc.br
Ceará
LOELOENUBBE- UNESP
Araraquara - São PauloDra. Vanderlan Bolzani
National Research Institute of Amazonia (INPA) - Amazonas
Dr. Adrian Pohlit
USP- Pharmacy School of Ribeirão Preto (USP - São Paulo)
Dr. Noberto Peporine
Depart. of Organic Chemistry (UFC) Dr. Edilberto Silveira, Telma Lemos
and Otilia Pessoa
Chemistry Institute of São Carlos (USP - São Paulo)
Dr. Roberto Gomes Berlinck
MOU between UFC and National Cancer Institute
Clinical Pharmacology UnitFederal University of Ceara-UFC
Dra. Maria Elisabete Moraes
Institute of Marine Sciences -(UFC)Dr. Tito Lotufo
CLEAR-CUTTING AND SLASH AND BURN DESTROYS NOT ONLY THE TREES AND MACRO-FAUNA BUT MUCH OF THE ASSOCIATED MICRO-FAUNA AND MICROBIALLIFE – AN INVALUABLE ANDIRREPLACABLE RESOURCE.